FNFWX | TEQSX | FNFWX / TEQSX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 4 years | 14 years | - |
Gain YTD | 7.040 | 7.260 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 60.9B | 6.91B | 881% |
Annual Yield % from dividends | 1.47 | 2.80 | 52% |
Returns for 1 year | 11.45 | 12.00 | 95% |
Returns for 3 years | -13.69 | -12.11 | 113% |
Returns for 5 years | N/A | 10.89 | - |
Returns for 10 years | N/A | 23.46 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CAIFX | 71.80 | -0.32 | -0.44% |
American Funds Capital Income Bldr F2 | |||
PIIQX | 11.46 | -0.06 | -0.52% |
Principal International Equity Index R5 | |||
MNCEX | 11.02 | -0.08 | -0.72% |
Mercer Non-US Core Equity Y3 | |||
FAOIX | 32.99 | -0.42 | -1.26% |
Fidelity Advisor Overseas I | |||
RYOAX | 61.01 | -2.83 | -4.43% |
Rydex Biotechnology H |